Syneron Medical (ELOS) Reports Q1 Adj-Loss of $0.23
More News related to ELOS
- Syneron Medical (ELOS) Posts Q3 Loss of 20c, Misses Views by 5c
- Syneron Reports Third Quarter 2009 Financial Results
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Syneron Medical to Announce Third Quarter 2009 Financial Results on November 9th, 2009
- Syneron Medical to Present at the Oppenheimer 20th Annual Healthcare Conference
More News related to Earnings
- Kinross Gold (KGC) Receives Authorization to Re-Commence Exploration on Project in Ecuador
- Sanofi-aventis (SNY) and Regeneron Pharmaceuticals (REGN) to Expand Global Collaboration
- Stryker (SYK) Announces Two Acquisitions
- Adobe (ADBE) Cutting 680 Full-Time Jobs to Align Costs with '10 Operating Plan
- Teva Pharma (TEVA) Gets Final U.S. FDA Approval for Generic Prevacid
Syneron Medical Ltd. (Nasdaq: ELOS) reports Q1 loss of $0.23, ex-items, versus the analyst estimate of ($0.16). Revenue for the quarter was $11.9 million, versus the consensus of $14.42 million.
Related Categories
EarningsStocks Mentioned
-0.72Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
